Gary, have you read this? Feds Lift Ban on Medical

New Post Public Reply Private Reply Replies (1) Message Board
moxaman GaryM #11702
576
Gary, have you read this?

Feds Lift Ban on Medical Marijuana

http://uspainclinic.com/2017/12/24/finally-wa...t-the-ban/

Eighty-five years ago marijuana was banned by federal statute and in the 1970’s marijuana was classified by the federal government as a controlled substance – drugs designated illegal, which could only be illicitly obtained. These drugs were often demonized as habit-forming associated with less desirable folks with addiction issues – not contributing to society – and the focus of the morally misguided failed federal ‘War on Drugs’. Interestingly, in 2013 according to a Gallup poll, for the first time some 58% of citizens supported legalization, yet marijuana is still on the federal controlled substance list alongside dangerous drugs such as heroin and meth. However, the use of medical marijuana has been approved by 23 states and the District of Columbia to help minimize the side-effects of diseases ranging from nausea and glaucoma to cancer and HIV/AIDS; used to treat ailments like multiple sclerosis and to help with chronic pain – but it was still banned on the federal leveluntil a provision that lifted the ban was “quietly placed in the recent spending bill” passed by Congress last week.

Despite the legalization of medical marijuana in these states and recent studies showing that it is not a gate-way drug – a drug the use of which leads to the use of other more addicting drugs – the federal government had retained the right to raid and harass medical marijuana dispensaries and prosecute their owners. This new legislation is a turning point in how the federal government views medical marijuanaand it had vigorous bi-partisan support.

Representative Dana Rohrabacher (R-CA), one of the bill’s co-authors commented:


“This is a victory for so many. The first time in decades that the federal government has curtailed its oppressive prohibition of marijuana”

On this historic move by Congress, Representative Sam Farr (D-CA) said:


“The federal government will finally respect the decisions made by the majority of states that passed medical marijuana laws. This is a great day for common sense because now our federal dollars will be spent more wisely on prosecuting criminals and not sick patients.”

This is a huge deal because up and until recently, Republicans have long been against any type of marijuana legalized, while Democrats have been in favor of relaxing the law. Fortunately, enough Republicans voted for the bill. Some have argued that the Republican change of heart is motivated by trying to lure the millennial demographic, “since the legalization of marijuana is a big issue with the millennials, So Republicans are now starting to ease up on their anti-marijuana rhetoric.”

It is also legal to fully purchase marijuana in four states for reasons other than medicinal use, but its full legalization is still prohibited by federal law. Bernie Sanders, who had sponsored legislation supporting states’ rights to legalize marijuana for medical use more than a decade ago, became the first candidate to endorse the full legalization of pot during the Democratic debate in October. Sanders rightfully seesour criminal justice system destroying too many lives by disproportionately mistreating non-violent drug offenders:


“I am seeing in this country too many lives being destroyed for non-violent offenses. We have a criminal justice system that lets CEOs on Wall Street walk away, and yet we are imprisoning or giving jail sentences to young people who are smoking marijuana. I think we have to think through this war on drugs…which has done an enormous amount of damage. We need to rethink our criminal justice system, we we’ve got a lot of work to do in that area.”

This is no doubt a turning point in legally allowing the use of pot to help people with legitimate medical needs for which the use of medicinal marijuana has been shown to provide relief. Perhaps, with the public in favor of full legalization of pot and politicians starting recognize how insidious it is to incarcerate non-violent drug offenders – principally people of color and minorities – full legalization is just around the corner.

OWC Pharmaceutical Research Corp. (OWCP) Stock Research Links

OWCP Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

FFR's OmniMind Takes Top Spot In RoboColiseum Rankings

Updated Category News Views 80

The AI Race Heats Up with FFR's Big Win Stop the presses—FFR's OmniMind AI just snagged the top spot on RoboColiseum's global rankings. Yeah, you heard right, this ain't just some run-of-the-mill news. As of November 6, they've parked themselves in pole position, beating out heavyweights like NVIDIA's GR00T N1.7 and GPT-6 Astra. That's like hitting a grand slam right...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 242

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 559

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 351

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 74

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 273

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Xiaomi's Smart Auto Factory Draws Global Media Praise

Updated Category News Views 25

Xiaomi Impresses Global Media in Beijing Factory Tour In the ever-changing world of NEVs (New Energy Vehicles), a tour of Xiaomi's smart auto factory in Beijing has made waves among global media folks. These scribes got an up-close look at Xiaomi's magic mix of tech and style on November 6, part of a grand media gathering. What's Under the Hood? Marcos Costa de Oliveira,...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 612

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 344

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 343

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading

Top 5 Most Recently Viewed Articles

Investors Alert: LifeMD Inc Faces Legal Investigation Risks

Updated Category News Views 167

Understanding Recent Developments for LifeMD, Inc. LifeMD, Inc. (NASDAQ: LFMD) is presently facing serious legal scrutiny following an investigation initiated by Faruqi & Faruqi, LLP. This renowned national securities law firm has stepped in to evaluate potential claims on behalf of investors. Investor Engagement Opportunities If you are among the investors who incurred...

Continue Reading
Value Stocks Poised for Growth Amid Market Shifts

Updated Category News Views 119

Value Stocks Set for Growth as Market Dynamics Change The stock market is currently experiencing a notable shift away from tech dominance. In recent months, tech stocks have faced challenges, raising questions about the potential revival of value stocks. This change in market sentiment is particularly evident in the impressive performance of the Value ETF, which has...

Continue Reading
EXEL Industries Reveals Key Share and Voting Rights Insights

Updated Category News Views 57

EXEL Industries Overview EXEL Industries is a prominent French Société Anonyme, with a robust share capital amounting to €16,969,750. The company has established a significant presence in the industry through its high standards and innovative products. Understanding Share Capital and Voting Rights On August 31, 2024, EXEL Industries provided updated insights regarding...

Continue Reading
Protective Life Corporation Strengthens Portfolio with Acquisition

Updated Category News Views 112

Protective Life Corporation Strengthens Its Portfolio In a significant development for Protective Life Corporation, the company has successfully completed the acquisition of ShelterPoint Group, Inc. Shielded under the corporate umbrella of Dai-ichi Life Holdings, Inc., Protective Life Corporation continues to solidify its position in the employee benefits industry. This...

Continue Reading
Safeguarding Your Personal Data in a Digital Health Era

Updated Category News Views 160

Understanding the Importance of Data Security in Health Tech As the holiday season approaches, consumers are excitedly purchasing various digital health tools such as fitness trackers, meditation apps, and smart scales. While these innovations can greatly enhance our wellness journey, they also raise significant concerns regarding the security of our personal data. Expert...

Continue Reading